Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTHi vaccine in COPD patients
NCT02075541Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2014
- Primary completion
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of NTHi-10-AS01E in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jul 2014; status: completed.
02
Drugs
NTHi-10-AS01E
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02075541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075541.